Tipp

Clinical consequences of the Calypso trial showing superiority of PEG-liposomal doxorubicin and carboplatin over paclitaxel and carboplatin in recurrent ovarian cancer: Results of an Austrian gynecologic oncologists' expert meeting

Autoren:: Edgar Petru, Alexander Reinthaller, Lukas Angleitner-Boubenizek, Christian Schauer, Alain Zeimet, Wolfgang Dirschlmayer, Michael Medl, Wolfgang Stummvoll, Paul Sevelda, Christian Marth

Jetzt informieren

Titel: Clinical consequences of the Calypso trial showing superiority of PEG-liposomal doxorubicin and carboplatin over paclitaxel and carboplatin in recurrent ovarian cancer: Results of an Austrian gynecologic oncologists' expert meeting
Autoren:: Edgar Petru
Alexander Reinthaller
Lukas Angleitner-Boubenizek
Christian Schauer
Alain Zeimet
Wolfgang Dirschlmayer
Michael Medl
Wolfgang Stummvoll
Paul Sevelda
Christian Marth
Publikationsdatum: 01.11.2010
DOI: https://doi.org/10.1007/s00508-010-1483-1
Verlag: Springer-Verlag
Zeitschrift: Wiener klinische Wochenschrift The Central European Journal of Medicine
Ausgabe 21-22/2010
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671